Literature DB >> 697538

Activities of types A and B MAO and catechol-o-methyltransferase in blood cells and skin fibroblasts of normal and chronic schizophrenic subjects.

R Groshong, R J Baldessarini, D A Gibson, J F Lipinski, D Axelrod, A Pope.   

Abstract

We assayed activities of monoamine oxidase (MAO) type B in blood platelets and type A (and B) in fibroblasts cultured from punch biopsy specimens of skin, as well as of catechol-O-methyltransferase (COMT) in erythrocytes and fibroblasts. Fibroblasts contained moderate amounts of both forms of MAO (types A and B) found in human brain and large amounts of COMT activity. Activities of both enzymes correlated poorly between fibroblasts and blood cells. Comparing carefully diagnosed chronic schizophrenics with age-matched normal young men, we found no difference in these biochemical variables, nor could we distinguish patients with paranoid symptoms. In contrast, we confirmed markedly lower MAO activities in platelet samples from chronic patients provided by colleagues at the National Institute of Mental Health. Results concerning MAO and COMT activities are now sufficiently inconsistently characteristic of schizophrenics as to question their clinical applicability and to indicate a need for further critical evaluation, with special attention to diagnosis, matching of subjects, and effects of possible spurious environmental variables.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 697538     DOI: 10.1001/archpsyc.1978.01770340048004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  7 in total

Review 1.  Human dermal fibroblasts in psychiatry research.

Authors:  S Kálmán; K A Garbett; Z Janka; K Mirnics
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

2.  Monoamine oxidase (MAO) activity as a determinant in human neurophysiology.

Authors:  J E Pintar; X O Breakefield
Journal:  Behav Genet       Date:  1982-02       Impact factor: 2.805

3.  Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.

Authors:  J J Mann; R D Kaplan; A Georgotas; E Friedman; M Branchey; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

4.  Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?

Authors:  A Fleissner; R Seifert; K Schneider; W Eckert; B Fuisting
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

Review 5.  The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Authors:  D C Ohuoha; T M Hyde; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Cocaine-sensitive O-methylation of noradrenaline in dental pulp of the rabbit: comparison with the rabbit ear artery.

Authors:  D A Parker; I S de la Lande; C Proctor; V Marino; N X Lam; I Parker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

Review 7.  Human platelet monoamine oxidase activity in health and disease: a review.

Authors:  M Sandler; M A Reveley; V Glover
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.